SIGN UP
LOG IN
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·07/24/2025 12:08:09
Listen to the news
Gainers
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 72.8% to $24.2 during Thursday's pre-market session. The market value of their outstanding shares is at $22.1 million.
- Liminatus Pharma (NASDAQ:LIMN) stock rose 27.08% to $8.22. The company's market cap stands at $170.5 million.
- Healthcare Triangle (NASDAQ:HCTI) stock increased by 25.0% to $0.03. The company's market cap stands at $10.2 million.
- Plus Therapeutics (NASDAQ:PSTV) stock rose 22.69% to $0.6. The market value of their outstanding shares is at $24.9 million.
- West Pharmaceutical Servs (NYSE:WST) stock moved upwards by 22.34% to $278.1. The company's market cap stands at $16.3 billion. As per the press release, Q2 earnings came out today.
- Cyclacel Pharmaceuticals (NASDAQ:CYCCP) shares increased by 16.12% to $5.4.
Losers
- Community Health Sys (NYSE:CYH) shares declined by 30.4% to $2.7 during Thursday's pre-market session. The company's market cap stands at $544.3 million. As per the news, the Q2 earnings report came out yesterday.
- Adagio Medical Holdings (NASDAQ:ADGM) shares declined by 19.21% to $1.43. The market value of their outstanding shares is at $27.2 million.
- Polyrizon (NASDAQ:PLRZ) stock decreased by 14.9% to $1.6. The market value of their outstanding shares is at $10.0 million.
- Palisade Bio (NASDAQ:PALI) stock declined by 13.94% to $1.05. The company's market cap stands at $6.0 million.
- Clearside Biomedical (NASDAQ:CLSD) stock decreased by 10.6% to $0.52. The market value of their outstanding shares is at $45.4 million.
- Hyperion DeFi (NASDAQ:HYPD) stock decreased by 9.88% to $8.4. The market value of their outstanding shares is at $47.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.